SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-05
👔
Inhibitor Therapeutics, Inc.
@INTI_InsiderForm 4 Filing: Black Robe Capital LLC Gifts shares of $INTI
INSIDER GIFT
⚡ MATERIALITY: 1/10
corporate issuer
Inhibitor Therapeutics, Inc.
Ticker: $INTI
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-01
Shares: 3,200,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Black Robe Capital LLC, holds the title of 10% Owner at Inhibitor Therapeutics, Inc..
On 2026-07-01, the insider transacted 3,200,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Black Robe Capital LLC (10% Owner) gifted $0 of $INTI
Post-Transaction Position: 19,901,057 shares
SEC Accession No: 0001493152-26-036080 (CIK: 1977553)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.